Choroidal structure of diabetic retinopathy eye on OCT image after the treatment

Choroidal structure of diabetic retinopathy eye on OCT image after the treatment - Choroidal structure of DR on OCT

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012154

Enrollment

Registered

2013-10-29

Start date

2013-10-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy

Interventions

Intravitreal injection of triamcinolone acetonide Intravitreal injection of anti-VEGF drug and follow up

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Aged 18 years or older. Diffuse DME(CMT 300microns < determined by OCT). Visual acuity: 1.0 logMAR >

Exclusion criteria

Exclusion criteria: Eyes with active proliferative DR. Eyes with known a history of glaucoma,optic nerve atrophy. History of laser photocoagulation within 3 months History of intravitreal injection or subrenon injection for diabetic macular edema within 3months. Aphakia Patients with any of serious heart disease, cerebrovascular disease,blood disorder, renal failure, malignant tumor, systemic steroids. Cases clear OCT images can not be obtained Patients with known as steroid responder

Design outcomes

Primary

Measure	Time frame
retinochodoiral strucure on OCT	—

Secondary

Measure	Time frame
Frequency of recurrence Complications visual acutiy	—

Countries

Japan

Contacts

Public ContactShozo Sonoda

Kagoshima University Graduate School of Medical and Dental Science Ophthalmology

shou@m2.kufm.kagoshima-u.ac.jp99-275-5402

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026